![Tomasz P. Stryjewski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tomasz P. Stryjewski
Fondatore presso Pykus Therapeutics, Inc.
Posizioni attive di Tomasz P. Stryjewski
Società | Posizione | Inizio | Fine |
---|---|---|---|
Pykus Therapeutics, Inc.
![]() Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Fondatore | 01/01/2016 | - |
Storia della carriera di Tomasz P. Stryjewski
Precedenti posizioni note di Tomasz P. Stryjewski
Società | Posizione | Inizio | Fine |
---|---|---|---|
Helio Vision, Inc.
![]() Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Fondatore | 01/01/2016 | - |
Statistiche
Distribuzione geografica
Stati Uniti | 3 |
Posizioni
Founder | 2 |
Settori
Health Technology | 2 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Helio Vision, Inc.
![]() Helio Vision, Inc. Pharmaceuticals: MajorHealth Technology Helio Vision, Inc. operates as a biotechnology company. It develops a therapy for fibroproliferative disorders that lead to abnormal scarring and blindness after retina surgery. The company was founded by Josef H. von Rickenbach, Dean Eliott and Tomasz P. Stryjewski in 2016 and is headquartered in Waltham, MA. | Health Technology |
Pykus Therapeutics, Inc.
![]() Pykus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Pykus Therapeutics, Inc. engages in the development of a dissolvable intraocular surgical device. It offers novel polymer that provides retinal tamponade. The company was founded by James Stefater and Tomasz Stryjewski and is headquartered in Boston, MA. | Commercial Services |
- Borsa valori
- Insiders
- Tomasz P. Stryjewski
- Esperienza